The global blood processing devices and consumables market size reached USD 55.7 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 98.6 Billion by 2033, exhibiting a growth rate (CAGR) of 6.22% during 2025-2033. The rising demand for blood and its products, supportive policies by governmental and non-governmental organizations, and the recent development of a closed blood sampling system represent some of the key factors driving the market.
Report Attribute
|
Key Statistics
|
---|---|
Base Year
|
2024
|
Forecast Years
|
2025-2033
|
Historical Years
|
2019-2024
|
Market Size in 2024 | USD 55.7 Billion |
Market Forecast in 2033 | USD 98.6 Billion |
Market Growth Rate (2025-2033) | 6.22% |
Blood processing devices and consumables refer to tools and materials used in the collection, processing, and transfusion of blood and its products. It includes tubes, bags, centrifuges, vials, freezers, filters, needles and syringes, blood culture systems, and plasma thawing devices. They are manufactured using various materials, such as plastic, glass, rubber, stainless steel, and titanium. Blood processing devices and consumables are widely used for blood storage, transport, separation, filtering, typing and cross-matching, irradiation, apheresis, and blood processing system. They enhance safety, increase efficiency, extend blood shelf-life, and minimize the risk of contamination, infections, and transfusion-related complications. Blood processing devices and consumables also aid in maintaining quality standards, reducing wastage, eliminating the need for manual sample handling, and ensuring the availability of blood and its products to healthcare facilities.
The rising demand for blood and its various products, such as white blood cells (WBCs), red blood cells (RBCs), and plasma, due to increasing numbers of surgical procedures, is one of the primary factors propelling the market growth. Blood processing devices and consumables are widely used in healthcare facilities to collect, process, transport, and store blood products, as they ensure safety, improve clinical efficiency, enhance patient safety, maintain blood efficacy, and prevent contaminations. In addition to this, the growing number of blood-related disorders, such as sickle cell anemia and thalassemia, is acting as another growth-inducing factor. Furthermore, the implementation of supportive policies by governmental and non-governmental organizations to promote blood donation, educate the masses, and provide funding for blood collection and processing programs is positively influencing the market growth. Additionally, the recent development of a closed blood sampling system, which utilizes a needleless connection between the blood collection set and the blood bag to reduce the risk of infection, contamination, and needlestick injuries, is providing an impetus to the market growth. Besides this, the introduction of automated blood processing systems, which carry out multiple steps simultaneously, thus improving overall efficiency, reducing manual labor, minimizing operational costs, and saving time, is contributing to market growth. Moreover, the rising demand for point-of-care testing that allows healthcare professionals to perform blood tests and collect samples quickly at patients’ homes is strengthening the market growth. Other factors, including the rapid expansion of the healthcare industry, increasing investments in the development of advanced devices, and the rising number of trauma cases, such as accidents, violence, and natural disaster, are anticipated to drive the market growth.
IMARC Group provides an analysis of the key trends in each segment of the global blood processing devices and consumables market, along with forecasts at the global, regional, and country levels from 2025-2033. Our report has categorized the market based on product and end user.
Product Insights:
The report has provided a detailed breakup and analysis of the blood processing devices and consumables market based on the product. This includes blood processing devices (blood bank freezers, blood grouping analyzers, blood warmer, blood cell processers, and others) and blood processing consumables (blood bags, blood lancets, vials, blood administration sets, and others). According to the report, blood processing devices represented the largest segment.
End User Insights:
A detailed breakup and analysis of the blood processing devices and consumables market based on the end user has also been provided in the report. This includes hospitals and clinics, diagnostic laboratories, and others. According to the report, hospitals and clinics accounted for the largest market share.
Regional Insights:
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for blood processing devices and consumables. Some of the factors driving the North America blood processing devices and consumables market included rising demand for blood and its products, favorable government policies, and rapid technological advancements.
The report has also provided a comprehensive analysis of the competitive landscape in the global blood processing devices and consumables market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Abbott Laboratories, BioMerieux SA (Institut Mérieux), Bio-Rad Laboratories Inc, Danaher Corporation, Grifols S.A., Haemonetics Corporation, Macopharma, Roche Holding AG, Terumo Corporation, Thermo Fisher Scientific Inc., ThermoGenesis Holdings, Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Billion USD |
Products Covered |
|
End Users Covered | Hospitals and Clinics, Diagnostic Laboratories, Others |
Regions Covered | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered | United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered | Abbott Laboratories, BioMerieux SA (Institut Mérieux), Bio-Rad Laboratories Inc, Danaher Corporation, Grifols S.A., Haemonetics Corporation, Macopharma, Roche Holding AG, Terumo Corporation, Thermo Fisher Scientific Inc., ThermoGenesis Holdings, Inc., etc. |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |